Invesco Ltd. Citius Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.6 - $0.9 $1,162 - $1,744	-1,938 Reduced 3.32%	56,355 $50,000
Q4 2023 Feb 12, 2024	BUY	$0.65 - $0.86 $6,008 - $7,949	9,244 Added 18.85%	58,293 $44,000
Q2 2023 Aug 11, 2023	BUY	$1.08 - $1.65 $52,972 - $80,930	49,049 New	49,049 $58,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.87 $28,783 - $61,165	-32,709 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.38 - $1.89 $993 - $1,360	720 Added 2.25%	32,709 $59,000
Q4 2021 Feb 14, 2022	SELL	$1.51 - $2.2 $34,116 - $49,706	-22,594 Reduced 41.39%	31,989 $49,000
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.6 $18,945 - $28,308	10,888 Added 24.92%	54,583 $110,000
Q2 2021 Aug 17, 2021	BUY	$1.51 - $4.23 $65,979 - $184,829	43,695 New	43,695 $152,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.